Balaxi Pharmaceuticals is trading 2.03% upper at Rs 29.10 as compared to its last closing price. Balaxi Pharmaceuticals has been trading in the price range of 29.30 & 28.70. Balaxi Pharmaceuticals has given 6.14% in this year & 6.90% in the last 5 days. Balaxi Pharmaceuticals has TTM P/E ratio 15.70 as compared to the sector P/E of 31.41.The company posted a net profit of 0.31 Crores in its last quarter.Listed peers of Balaxi Pharmaceuticals include Aurobindo Pharma (0.67%), Pfizer (1.06%), Neuland Laboratories (2.65%).The Mutual Fund holding in Balaxi Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Balaxi Pharmaceuticals was at 1.74% in 31 Dec 2025. The FII holding has decreased from the last quarter.
Updated on May 08, 2026, 12:32 PM UTC
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | Bullish | 1,488.50 | 0.67 | 86,303.47 | 22.75 | 2.43 | 0.29 | 5.52 |
| Pfizer | Moderately Bearish | 4,800.00 | 1.06 | 21,939.05 | 35.10 | 5.31 | 0.72 | 1.60 |
| Neuland Laboratories | Bullish | 17,759.00 | 2.65 | 22,784.60 | 93.67 | 12.79 | 0.08 | 7.17 |
| Unichem Laboratories | Moderately Bullish | 384.55 | -1.89 | 2,694.73 | 17.85 | 0.99 | - | 3.51 |
| Jagsonpal Pharmaceuticals | Bullish | 216.50 | 1.48 | 1,455.95 | 31.40 | 5.13 | 1.35 | 3.18 |
| Meeting Date | Purpose |
|---|---|
| 2026-01-28 | Quarterly Results & Others |
| 2025-11-11 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-30 | Audited Results & Others |
| 2025-02-10 | Quarterly Results & Others |
Balaxi Pharmaceuticals is trading at 29.10 as on Fri May 08 2026 09:58:12. This is 2.03% upper as compared to its previous closing price of 28.52.
The market capitalization of Balaxi Pharmaceuticals is 160.65 Cr as on Fri May 08 2026 09:58:12.
The 52 wk high for Balaxi Pharmaceuticals is 63.90 whereas the 52 wk low is 15.20
Balaxi Pharmaceuticals can be analyzed on the following key metrics -
Balaxi Pharmaceuticals reported a net profit of 25.07 Cr in 2025.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.